Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Goodwill (2019 - 2025)

Revolution Medicines (RVMD) has 7 years of Goodwill data on record, last reported at $14.6 million in Q4 2025.

  • For Q4 2025, Goodwill changed 0.0% year-over-year to $14.6 million; the TTM value through Dec 2025 reached $14.6 million, changed 0.0%, while the annual FY2025 figure was $14.6 million, 0.0% changed from the prior year.
  • Goodwill reached $14.6 million in Q4 2025 per RVMD's latest filing, roughly flat from $14.6 million in the prior quarter.
  • Across five years, Goodwill topped out at $14.6 million in Q1 2021 and bottomed at $14.6 million in Q1 2021.
  • Average Goodwill over 5 years is $14.6 million, with a median of $14.6 million recorded in 2021.
  • The widest YoY moves for Goodwill: up 0.0% in 2021, down 0.0% in 2021.
  • A 5-year view of Goodwill shows it stood at $14.6 million in 2021, then changed by 0.0% to $14.6 million in 2022, then changed by 0.0% to $14.6 million in 2023, then changed by 0.0% to $14.6 million in 2024, then changed by 0.0% to $14.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $14.6 million in Q4 2025, $14.6 million in Q3 2025, and $14.6 million in Q2 2025.